Oligometastatic neuroendocrine tumors: characteristics and prognosis. [PDF]
Melhorn P +3 more
europepmc +1 more source
Lymphocyte Kinetics and Outcomes After Comprehensive Involved-Site Radiotherapy for Oligometastases. [PDF]
Patel D +4 more
europepmc +1 more source
Bevacizumab plus iparomlimab/tuvonralimab with hepatic artery infusion chemotherapy followed by stereotactic body radiotherapy in patients with BCLC stage C hepatocellular carcinoma with thrombus and/or extrahepatic oligometastases (BITS-TO-HCC): study protocol of a prospective, single-center, single-arm, phase II study. [PDF]
Liu Y +13 more
europepmc +1 more source
Bibliometric analysis of stereotactic ablative radiotherapy for oligometastases. [PDF]
Di Y, Song Z, Wang Y, Meng L, Li J.
europepmc +1 more source
Oligometastatic Prostate Cancer: Clues from an N-of-1. [PDF]
Kirschenbaum A +7 more
europepmc +1 more source
Editorial: New Approaches to Breast Cancer Radiotherapy
Geraldine Meerbott Jacobson +1 more
doaj +1 more source
Phase II Study of Dose-Escalated and Convergent Stereotactic Body Radiotherapy for Liver and Pulmonary Oligometastases from Colorectal Cancer. [PDF]
Nishimura S +5 more
europepmc +1 more source
Oligometastases: Incorporate the patient perspective to ensure optimal treatment and care
Hilde M. Buiting +5 more
openaire +2 more sources
Single- Versus Multi-Fraction Stereotactic Body Radiotherapy for Primary Lung Cancer and Pulmonary Oligometastases: A Systematic Review and Meta-Analyses. [PDF]
Pillay I, Gee H, Hau E, Ong A, Gebski V.
europepmc +1 more source
Future directions of image-guided thermal ablation in colorectal cancer lung oligometastases. [PDF]
Wang YY +5 more
europepmc +1 more source

